CHAMPIONS ONCOLOGY, INC. Lease Obligation Incurred
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Lease Obligation Incurred of $412.00 thousand for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-11.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalLeaseObligationsIncurred · last filed 2026-09-11
- CHAMPIONS ONCOLOGY, INC. lease obligation incurred for the quarter ending 2026-07-31 was $412.00K.
- CHAMPIONS ONCOLOGY, INC. lease obligation incurred for the quarter ending 2025-07-31 was $0.00.
- CHAMPIONS ONCOLOGY, INC. lease obligation incurred for the quarter ending 2020-04-30 was $0.00.
- CHAMPIONS ONCOLOGY, INC. lease obligation incurred for the quarter ending 2020-01-31 was $212.00K.
- CHAMPIONS ONCOLOGY, INC. lease obligation incurred for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- CHAMPIONS ONCOLOGY, INC. lease obligation incurred for fiscal 2023 was $368.00K.
- CHAMPIONS ONCOLOGY, INC. lease obligation incurred for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- CHAMPIONS ONCOLOGY, INC. lease obligation incurred for fiscal 2020 was $212.00K, a 9.79% decline from fiscal 2019.
| Period end | Lease Obligation Incurred 3 month | Lease Obligation Incurred 6 month | Lease Obligation Incurred 9 month | Lease Obligation Incurred 12 month |
|---|---|---|---|---|
| 2026-07-31 | $412.00K 10-Q · filed 2026-09-11 | |||
| 2025-07-31 | $0.00 10-Q · filed 2026-09-11 | |||
| 2024-04-30 | $0.00 10-K · filed 2024-07-19 | |||
| 2023-04-30 | $368.00K 10-K · filed 2024-07-19 | |||
| 2021-04-30 | $0.00 10-K · filed 2021-07-26 | |||
| 2020-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-26 | $212.00K derived: sum of 2 quarters · filed 2021-07-26 | $212.00K derived: sum of 3 quarters · filed 2021-07-26 | $212.00K 10-K · filed 2021-07-26 |
| 2020-01-31 | $212.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-03-16 | $212.00K derived: sum of 2 quarters · filed 2020-03-16 | $212.00K 10-Q · filed 2020-03-16 | $212.00K derived: sum of 4 quarters · filed 2020-07-28 |
| 2019-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-12-16 | $0.00 10-Q · filed 2019-12-16 | $0.00 derived: sum of 3 quarters · filed 2020-07-28 | $0.00 derived: sum of 4 quarters · filed 2020-07-28 |
| 2019-07-31 | $0.00 10-Q · filed 2019-09-16 | $0.00 derived: sum of 2 quarters · filed 2020-07-28 | $0.00 derived: sum of 3 quarters · filed 2020-07-28 | -$14.00K derived: sum of 4 quarters · filed 2020-07-28 |
| 2019-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-28 | $0.00 derived: sum of 2 quarters · filed 2020-07-28 | -$14.00K derived: sum of 3 quarters · filed 2020-07-28 | $235.00K 10-K · filed 2020-07-28 |
| 2019-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-03-16 | -$14.00K derived: sum of 2 quarters · filed 2020-03-16 | $235.00K 10-Q · filed 2020-03-16 | $235.00K derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-10-31 | -$14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-12-16 | $235.00K 10-Q · filed 2019-12-16 | $235.00K derived: sum of 3 quarters · filed 2019-12-16 | $235.00K derived: sum of 4 quarters · filed 2019-12-16 |
| 2018-07-31 | $249.00K 10-Q · filed 2019-09-16 | $249.00K derived: sum of 2 quarters · filed 2019-09-16 | $249.00K derived: sum of 3 quarters · filed 2019-09-16 | $249.00K derived: sum of 4 quarters · filed 2019-09-16 |
| 2018-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-29 | $0.00 derived: sum of 2 quarters · filed 2019-07-29 | $0.00 derived: sum of 3 quarters · filed 2019-07-29 | $0.00 10-K · filed 2019-07-29 |
| 2018-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-18 | $0.00 derived: sum of 2 quarters · filed 2019-03-18 | $0.00 10-Q · filed 2019-03-18 | |
| 2017-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-12-17 | $0.00 10-Q · filed 2018-12-17 | ||
| 2017-07-31 | $0.00 10-Q · filed 2018-09-14 | |||
| 2016-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | $0.00 10-K · filed 2016-07-29 | ||
| 2016-01-31 | $0.00 10-Q · filed 2016-03-16 | |||
| 2015-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | $124.00K 10-K · filed 2016-07-29 | ||
| 2015-01-31 | $124.00K 10-Q · filed 2016-03-16 | |||
| 2014-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-29 | $0.00 10-K · filed 2015-07-29 | ||
| 2014-01-31 | $0.00 10-Q · filed 2015-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |